Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results

Fig. 4

Resolution of polyps on aflibercept in an Asian Male with a large vascular PCV complex persisting after 24 months of high dose ranibizumab therapy (PEARL2, 6 2.0 mg ranibizumab + 18 1.0 mg ranibizumab injections). a. EPIC baseline ICG angiogram showing persistent polyps (circles). b-d. EPIC baseline images with ICG angiogram and corresponding polyps (arrows) on OCT. e. Epic month 6 ICG angiogram showing marked polyp resolution. f-h. EPIC month 6 ICG angiogram with corresponding OCT images displaying significant polyp (arrows) reduction on aflibercept therapy

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us